Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review.

Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. Pharmacoeconomics. 2020 09; 38(9):927-939.

View in: PubMed